Liquidia › Biotech Liquidia (NASDAQ: LQDA) had good news to report about its latest commercialized product as the trading ...
LEXINGTON, Ky. (WKYT) - Harrison Memorial Hospital is now offering a new procedure for patients struggling with high blood ...
In a lawsuit, the widow of a man who died in the Wayne County Correctional Facility says “pervasive mold” in the jail ...
Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in ...
Pediatric kidney disease requires early diagnosis and specialized care to support growth, development, and long-term health.
Liquidia reported strong patient adoption since YUTREPIA’s launch in June 2025, receiving more than 2,800 unique patient prescriptions through December. The company has started treatment for more than ...
Background The epidemiology of native valve infective endocarditis (IE) has shifted toward older adults with substantial ...
When not guiding students in a compassionate approach to patient care, he led a tiny publishing imprint that put out a ...
The case became increasingly complex as the tumour encased the portal vein, the main vessel supplying blood to the intestines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback